Home › Asset managers › DWS › 2024-2025 › Against the board
Two kinds of vote are listed: a board-sponsored proposal DWS voted AGAINST or withheld on, and a shareholder proposal it voted FOR, with the board’s recommendation on it where the filings show one. A FOR vote on a proposal the board supported, or took no position on, is listed and labelled, but it is not a vote against the board. One row is one proposal at one meeting; “funds” is how many of the manager’s funds or accounts voted that way.
Everything Only shareholder proposals it backed
6,218 proposals. The board-sponsored half of this list keeps the 6,000 proposals with the most funds behind them; the rest are in the interactive database. Every shareholder proposal it backed is listed in full.
| Company | Meeting | Proposal | Category | On the ballot from | Board recommended | DWS voted | Funds |
|---|---|---|---|---|---|---|---|
| ARISTON HOLDING NV | June 3, 2025 | Amend Remuneration Policy | Compensation | Board | AGAINST | 1 | |
| ARISTON HOLDING NV | June 3, 2025 | Approve 2025 Share Unit Plan | Compensation | Board | AGAINST | 1 | |
| ARISTON HOLDING NV | June 3, 2025 | Approve Remuneration Report | Compensation | Board | AGAINST | 1 | |
| ARNOLDO MONDADORI EDITORE SPA | April 16, 2025 | Approve Second Section of the Remuneration Report | Compensation | Board | AGAINST | 1 | |
| ARRAY TECHNOLOGIES INC. | May 20, 2025 | Advisory vote to approve named executive officer compensation. | Say-on-Pay | Board | AGAINST | 1 | |
| ARRAY TECHNOLOGIES INC. | May 20, 2025 | ELECTION OF CLASS II DIRECTORS: Jayanthi Iyengar | Director Elections | Board | WITHHOLD | 1 | |
| ARROWHEAD PHARMACEUTICALS INC. | March 12, 2025 | Election of Directors: Douglas Ingram | Director Elections | Board | AGAINST | 1 | |
| ARS Pharmaceuticals, Inc. | June 25, 2025 | To elect the four nominees for Class II director named in the proxy statement to serve for three-year terms until the 2028 Annual Meeting of Stockholders: Richard Lowenthal | Director Elections | Board | WITHHOLD | 1 | |
| ARVINAS INC. | June 25, 2025 | Election of three Class I directors: John Houston, Ph.D. | Director Elections | Board | WITHHOLD | 1 | |
| ARVINAS INC. | June 25, 2025 | Election of three Class I directors: Laurie Smaldone Alsup, M.D. | Director Elections | Board | WITHHOLD | 1 | |
| ARVINAS INC. | June 25, 2025 | Election of three Class I directors: Linda Bain | Director Elections | Board | WITHHOLD | 1 | |
| AS ONE CORP. | June 26, 2025 | Elect Director and Audit Committee Member Suzuki, Kazutaka | Director Elections | Board | AGAINST | 1 | |
| ASAHI INTECC CO. LTD. | September 26, 2024 | Elect Director and Audit Committee Member Moriguchi, Shigeki | Director Elections | Board | AGAINST | 1 | |
| ASCOPIAVE SPA | April 16, 2025 | Approve Remuneration Policy | Compensation | Board | AGAINST | 1 | |
| ASCOPIAVE SPA | April 16, 2025 | Approve Second Section of the Remuneration Report | Compensation | Board | AGAINST | 1 | |
| ASCOPIAVE SPA | April 16, 2025 | Authorize Share Repurchase Program and Reissuance of Repurchased Shares | Capital Structure | Board | AGAINST | 1 | |
| ASKUL CORP. | August 8, 2024 | Appoint Statutory Auditor Asaeda, Yoshitaka | Compensation | Board | AGAINST | 1 | |
| ASMEDIA TECHNOLOGY INC. | June 13, 2025 | Approve Issuance of Restricted Stocks | Compensation | Board | AGAINST | 1 | |
| ASP Isotopes Inc. | November 20, 2024 | Approval of the Quantum Leap Energy LLC 2024 Equity Incentive Plan, as amended. | Compensation | Board | AGAINST | 1 | |
| ASP Isotopes Inc. | November 20, 2024 | Election of directors to serve as Class II directors for a three-year term: Duncan Moore, Ph.D. | Director Elections | Board | WITHHOLD | 1 | |
| ASP Isotopes Inc. | November 20, 2024 | Election of directors to serve as Class II directors for a three-year term: Michael Gorley, Ph.D. | Director Elections | Board | WITHHOLD | 1 | |
| ASPEN AEROGELS INC. | April 30, 2025 | Approval of the Aspen Aerogels Amended and Restated 2023 Equity Incentive Plan. | Compensation | Board | AGAINST | 1 | |
| ASPEN AEROGELS INC. | April 30, 2025 | Election of Directors: Kathleen M. Kool | Director Elections | Board | WITHHOLD | 1 | |
| ASPEN AEROGELS INC. | April 30, 2025 | Election of Directors: William P. Noglows | Director Elections | Board | WITHHOLD | 1 | |
| ASSYSTEM SA | May 23, 2025 | Approve Compensation of Dominique Louis, Chairman and CEO | Compensation | Board | AGAINST | 1 | |
| ASSYSTEM SA | May 23, 2025 | Approve Compensation of Stephane Aubarbier, Vice-CEO | Compensation | Board | AGAINST | 1 | |
| ASSYSTEM SA | May 23, 2025 | Approve Issuance of 470,046 Warrants (BSA and/or BSAAR) without Preemptive Rights Reserved for Employees and Corporate Officers | Compensation | Board | AGAINST | 1 | |
| ASSYSTEM SA | May 23, 2025 | Approve Issuance of Equity or Equity-Linked Securities Reserved for Qualified Investors or Restricted Number of Investors, up to Aggregate Nominal Amount of EUR 4.5 Million | Capital Structure | Board | AGAINST | 1 | |
| ASSYSTEM SA | May 23, 2025 | Approve Remuneration Policy of Corporate Officers | Compensation | Board | AGAINST | 1 | |
| ASSYSTEM SA | May 23, 2025 | Approve Remuneration Policy of Vice-CEOs | Compensation | Board | AGAINST | 1 | |
| ASSYSTEM SA | May 23, 2025 | Authorize Board to Increase Capital in the Event of Additional Demand Related to Delegation Submitted to Shareholder Vote Under Items 15 to 17 | Capital Structure | Board | AGAINST | 1 | |
| ASSYSTEM SA | May 23, 2025 | Authorize Issuance of Equity or Equity-Linked Securities with Preemptive Rights up to Aggregate Nominal Amount of EUR 10 Million | Capital Structure | Board | AGAINST | 1 | |
| ASSYSTEM SA | May 23, 2025 | Authorize Issuance of Equity or Equity-Linked Securities without Preemptive Rights up to Aggregate Nominal Amount of EUR 4.5 Million | Capital Structure | Board | AGAINST | 1 | |
| ASSYSTEM SA | May 23, 2025 | Authorize Repurchase of Up to 10 Percent of Issued Share Capital | Capital Structure | Board | AGAINST | 1 | |
| ASSYSTEM SA | May 23, 2025 | Authorize up to 3 Percent of Issued Capital for Use in Restricted Stock Plans | Compensation | Board | AGAINST | 1 | |
| ASSYSTEM SA | May 23, 2025 | Authorize up to 3 Percent of Issued Capital for Use in Stock Option Plans | Compensation | Board | AGAINST | 1 | |
| AST SPACEMOBILE INC. | June 6, 2025 | To approve a non-binding advisory vote on the compensation paid to the Company's named executive officers. | Say-on-Pay | Board | AGAINST | 1 | |
| AST Spacemobile, Inc. | September 10, 2024 | To approve the AST SpaceMobile, Inc. 2024 Incentive Award Plan. | Compensation | Board | AGAINST | 1 | |
| ASYMCHEM LABORATORIES (TIANJIN) CO. LTD. | April 3, 2025 | Approve 10% Mandate Limit and H Share Scheme Mandate Limit Subject to the Adoption of H Share Restricted Share Scheme | Compensation | Board | AGAINST | 1 | |
| ASYMCHEM LABORATORIES (TIANJIN) CO. LTD. | April 3, 2025 | Approve 2025 A Share Scheme | Compensation | Board | AGAINST | 1 | |
| ASYMCHEM LABORATORIES (TIANJIN) CO. LTD. | April 3, 2025 | Approve Assessment Management Measures for 2025 A Share Restricted Shares Incentive Scheme | Compensation | Board | AGAINST | 1 | |
| ASYMCHEM LABORATORIES (TIANJIN) CO. LTD. | April 3, 2025 | Approve H Share Restricted Share Scheme | Compensation | Board | AGAINST | 1 | |
| ASYMCHEM LABORATORIES (TIANJIN) CO. LTD. | April 3, 2025 | Approve Proposed Grants to Directors Under the H Share Restricted Share Scheme | Compensation | Board | AGAINST | 1 | |
| ASYMCHEM LABORATORIES (TIANJIN) CO. LTD. | April 3, 2025 | Approve Service Provider Sublimit Subject to the Adoption of H Share Restricted Share Scheme | Compensation | Board | AGAINST | 1 | |
| ASYMCHEM LABORATORIES (TIANJIN) CO. LTD. | April 3, 2025 | Authorize Board and/or Its Delegatee(s) to Handle Matters in Relation to the H Share Restricted Share Scheme | Compensation | Board | AGAINST | 1 | |
| ASYMCHEM LABORATORIES (TIANJIN) CO. LTD. | April 3, 2025 | Authorize Board to Handle Matters in Relation to the 2025 A Share Scheme | Compensation | Board | AGAINST | 1 | |
| ASYMCHEM LABORATORIES (TIANJIN) CO. LTD. | June 11, 2025 | Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights for A Shares and/or H Shares | Capital Structure | Board | AGAINST | 1 | |
| AT & S AUSTRIA TECHNOLOGIE & SYSTEMTECHNIK AG | July 4, 2024 | Approve Remuneration Report | Compensation | Board | AGAINST | 1 | |
| AT & S AUSTRIA TECHNOLOGIE & SYSTEMTECHNIK AG | July 4, 2024 | Elect Georg Riedl as Supervisory Board Member | Director Elections | Board | AGAINST | 1 | |
| AT & S AUSTRIA TECHNOLOGIE & SYSTEMTECHNIK AG | July 4, 2024 | Elect Gertrude Tumpel-Gugerell as Supervisory Board Member | Director Elections | Board | AGAINST | 1 | |
| AT & S AUSTRIA TECHNOLOGIE & SYSTEMTECHNIK AG | July 4, 2024 | Elect Karin Schaupp as Supervisory Board Member | Director Elections | Board | AGAINST | 1 | |
| ATHENS INTERNATIONAL AIRPORT SA | April 14, 2025 | Approve Auditors and Fix Their Remuneration | Audit-related | Board | AGAINST | 1 | |
| ATHENS INTERNATIONAL AIRPORT SA | April 14, 2025 | Approve Director Remuneration | Compensation | Board | AGAINST | 1 | |
| ATHENS INTERNATIONAL AIRPORT SA | April 14, 2025 | Receive Remuneration Report | Compensation | Board | AGAINST | 1 | |
| ATOSS SOFTWARE SE | April 30, 2025 | Approve Remuneration Policy | Compensation | Board | AGAINST | 1 | |
| ATOSS SOFTWARE SE | April 30, 2025 | Approve Remuneration Report | Compensation | Board | AGAINST | 1 | |
| ATOSS SOFTWARE SE | April 30, 2025 | Elect Klaus Bauer to the Supervisory Board | Director Elections | Board | AGAINST | 1 | |
| ATOSS SOFTWARE SE | April 30, 2025 | Elect Moritz Zimmermann to the Supervisory Board | Director Elections | Board | AGAINST | 1 | |
| ATOSS SOFTWARE SE | April 30, 2025 | Elect Rolf Vielhauer von Hohenhau to the Supervisory Board | Director Elections | Board | AGAINST | 1 | |
| ATRESMEDIA CORPORACION DE MEDIOS DE COMUNICACION SA | April 29, 2025 | Amend Remuneration Policy | Compensation | Board | AGAINST | 1 | |
| ATRESMEDIA CORPORACION DE MEDIOS DE COMUNICACION SA | April 29, 2025 | Authorize Issuance of Convertible Bonds, Debentures, Warrants, and Other Debt Securities up to EUR 300 Million with Exclusion of Preemptive Rights up to 20 Percent of Capital | Capital Structure | Board | AGAINST | 1 | |
| ATRIUM LJUNGBERG AB | March 20, 2025 | Reelect Johan Thorell as Director | Director Elections | Board | AGAINST | 1 | |
| AUBAY SA | May 6, 2025 | Authorize up to 1 Percent of Issued Capital for Use in Stock Option Plans | Compensation | Board | AGAINST | 1 | |
| AUDAX RENOVABLES SA | June 19, 2025 | Advisory Vote on Remuneration Report | Compensation | Board | AGAINST | 1 | |
| AUDAX RENOVABLES SA | June 19, 2025 | Approve Remuneration Policy | Compensation | Board | AGAINST | 1 | |
| AUDAX RENOVABLES SA | June 19, 2025 | Authorize Increase in Capital up to 50 Percent via Issuance of Equity or Equity-Linked Securities, Excluding Preemptive Rights of up to 20 Percent | Capital Structure | Board | AGAINST | 1 | |
| AUDAX RENOVABLES SA | June 19, 2025 | Authorize Issuance of Convertible Bonds, Debentures, Warrants, and Other Debt Securities up to EUR 300 Million with Exclusion of Preemptive Rights up to 20 Percent of Capital | Capital Structure | Board | AGAINST | 1 | |
| AUDAX RENOVABLES SA | June 19, 2025 | Reelect Ana Isabel Lopez Porta as Director | Director Elections | Board | AGAINST | 1 | |
| AUTOBIO DIAGNOSTICS CO. LTD. | May 8, 2025 | Approve Remuneration of Directors and Senior Management Members | Compensation | Board | AGAINST | 1 | |
| AVIDITY BIOSCIENCES INC. | June 10, 2025 | To consider and vote upon, on an advisory basis, the compensation of our named executive officers as disclosed in this proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission; and | Say-on-Pay | Board | AGAINST | 1 | |
| AVITA Medical, Inc. | June 4, 2025 | To approve (a) the 2020 Omnibus Incentive Plan Amended and Restated (the "Plan"), the terms of which are summarized in this Proxy Statement; and (b) for purposes of ASX Listing Rule 7.2 Exception 13(b), which provides an exception to ASX Listing Rule 7.1, the issuance of the Company's equity securities under the Plan, in accordance with its terms and conditions, for a period of up to three years from the date of stockholder approval. | Compensation | Board | AGAINST | 1 | |
| AXFOOD AB | March 19, 2025 | Approve Remuneration Report | Compensation | Board | AGAINST | 1 | |
| AXSOME THERAPEUTICS INC. | June 6, 2025 | Election of Director: Roger Jeffs, Ph.D. | Director Elections | Board | WITHHOLD | 1 | |
| AXSOME THERAPEUTICS INC. | June 6, 2025 | To approve the Company's 2025 Long-Term Incentive Plan. | Compensation | Board | AGAINST | 1 | |
| AYVENS SA | May 19, 2025 | Authorize Capital Increase of up to 20 Percent of Issued Capital for Contributions in Kind | Capital Structure | Board | AGAINST | 1 | |
| AYVENS SA | May 19, 2025 | Ratify Appointment of Clara Levy-Barouch as Director | Director Elections | Board | AGAINST | 1 | |
| AZELIS GROUP NV | May 8, 2025 | Approve Remuneration Report | Compensation | Board | AGAINST | 1 | |
| AZIMUT HOLDING SPA | April 30, 2025 | Approve Remuneration Policy | Compensation | Board | AGAINST | 1 | |
| Accolade, Inc. | August 6, 2024 | Election of Directors: Cindy Kent | Director Elections | Board | WITHHOLD | 1 | |
| Achieve Life Sciences, Inc. | June 4, 2025 | To approve an amendment to our 2023 Non-Employee Director Equity Incentive Plan to increase the number of shares available for issuance thereunder. | Compensation | Board | AGAINST | 1 | |
| Acrivon Therapeutics, Inc. | June 13, 2025 | Election of Class III Directors: Derek DiRocco, Ph.D. | Director Elections | Board | WITHHOLD | 1 | |
| Acrivon Therapeutics, Inc. | June 13, 2025 | Election of Class III Directors: Santhosh Palani, Ph.D., C.F.A. | Director Elections | Board | WITHHOLD | 1 | |
| Acumen Pharmaceuticals, Inc. | June 4, 2025 | To elect three Class I directors, to the Board of Directors, each to hold office until the 2028 Annual Meeting of Stockholders, and until his or her successor shall have been duly elected and qualified: Kimberlee C. Drapkin | Director Elections | Board | WITHHOLD | 1 | |
| Acushnet Holdings Corp. | June 2, 2025 | Election of the following nominees for director: David Maher | Director Elections | Board | WITHHOLD | 1 | |
| Acushnet Holdings Corp. | June 2, 2025 | Election of the following nominees for director: Ho Yeon (Aaron) Lee | Director Elections | Board | WITHHOLD | 1 | |
| Acushnet Holdings Corp. | June 2, 2025 | Election of the following nominees for director: Keun Chang (Kevin) Yoon | Director Elections | Board | WITHHOLD | 1 | |
| Acushnet Holdings Corp. | June 2, 2025 | Election of the following nominees for director: Yoon Soo (Gene) Yoon | Director Elections | Board | WITHHOLD | 1 | |
| Adaptive Biotechnologies Corporation | June 10, 2025 | To elect one Class III director nominee to serve on the board of directors of Adaptive Biotechnologies Corporation for a three-year term expiring at the 2028 annual meeting of shareholders: Chad Robins | Director Elections | Board | WITHHOLD | 1 | |
| Advantage Solutions Inc. | May 28, 2025 | To approve, on a advisory (non-binding) basis, the compensation of Advantage Solution Inc's named executive officers. | Say-on-Pay | Board | AGAINST | 1 | |
| Adverum Biotechnologies, Inc. | June 17, 2025 | Election of Class II Directors: James Scopa | Director Elections | Board | WITHHOLD | 1 | |
| Adverum Biotechnologies, Inc. | June 17, 2025 | Election of Class II Directors: Laurent Fischer, M.D. | Director Elections | Board | WITHHOLD | 1 | |
| Adverum Biotechnologies, Inc. | June 17, 2025 | Election of Class II Directors: Patrick Machado | Director Elections | Board | WITHHOLD | 1 | |
| Adverum Biotechnologies, Inc. | June 17, 2025 | To approve the amendment and restatement of the Adverum Biotechnologies, Inc. 2024 Equity Incentive Award Plan. | Compensation | Board | AGAINST | 1 | |
| Adverum Biotechnologies, Inc. | June 17, 2025 | To approve the amendment of certain outstanding stock options to reduce the exercise price per share to the closing price on the date of repricing. | Compensation | Board | AGAINST | 1 | |
| AerSale Corporation | June 5, 2025 | To approve the Second Amendment to the AerSale Corporation 2020 Equity Incentive Plan; | Compensation | Board | AGAINST | 1 | |
| Aerovate Therapeutics, Inc. | April 16, 2025 | To approve the Jade Biosciences, Inc. 2025 Stock Incentive Plan (the "Stock Plan Proposal" or "Proposal No. 5"); | Compensation | Board | AGAINST | 1 | |
| Aeva Technologies, Inc. | June 20, 2025 | Approval, on a non-binding advisory basis, the compensation of our named executive officers. | Say-on-Pay | Board | AGAINST | 1 | |
| Aeva Technologies, Inc. | June 20, 2025 | Election of Class I Directors: Stefan Sommer, Ph. D. | Director Elections | Board | WITHHOLD | 1 | |
| Affirm Holdings, Inc. | December 9, 2024 | To elect the three Class I nominees for director named in the accompanying proxy statement to hold office until the 2027 Annual Meeting and until their successors have been duly elected and qualified or until such director's earlier death, resignation or removal: Libor Michalek | Director Elections | Board | AGAINST | 1 | |
| Affirm Holdings, Inc. | June 25, 2025 | To approve the reincorporation of the Company from the State of Delaware to the State of Nevada by conversion. | Extraordinary Transactions | Board | AGAINST | 1 |
← Previous Page 38 of 63 Next →
← Back to DWS 2024-2025 overview
Built November 1, 2026 from SEC Form N-PX filings.